Publication | Open Access
High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
66
Citations
51
References
2018
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1